Current Net Margin
-3014.93%
Entrada Therapeutics, Inc. currently has a net profit margin of -3014.93%.
Financial Fundamentals
TRDA • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.00 | -0.04 | -3014.93% | ▼28049 |
| 2025-09-30 | 0.00 | -0.04 | -2734.45% | ▼52404 |
| 2025-06-30 | 0.00 | -0.04 | -2210.41% | ▼212602 |
| 2025-03-31 | 0.02 | -0.02 | -84.39% | ▼8741 |
| 2024-12-31 | 0.04 | 0.00 | 3.02% | ▲7473 |
| 2024-09-30 | 0.02 | -0.01 | -71.70% | ▼12982 |
| 2024-06-30 | 0.09 | 0.06 | 58.11% | ▲1837 |
| 2024-03-31 | 0.06 | 0.02 | 39.74% | ▲6255 |
| 2023-12-31 | 0.04 | -0.01 | -22.81% | ▼10389 |
| 2023-09-30 | 0.04 | 0.04 | 81.08% | ▲22378 |
| 2023-06-30 | 0.02 | -0.03 | -142.70% | ▼11628 |
| 2023-03-31 | 0.03 | -0.01 | -26.42% | — |
| 2022-12-31 | 0.00 | -0.02 | — | — |
| 2022-09-30 | 0.00 | -0.03 | — | — |
| 2022-06-30 | 0.00 | -0.02 | — | — |
| 2022-03-31 | 0.00 | -0.02 | — | — |
| 2021-12-31 | 0.00 | -0.02 | — | — |
| 2021-09-30 | 0.00 | -0.01 | — | — |
| 2021-06-30 | 0.00 | -0.01 | — | — |
| 2021-03-31 | 0.00 | -0.01 | — | — |
| 2020-12-31 | 0.00 | -0.01 | — | — |
| 2020-09-30 | 0.00 | -0.01 | — | — |
| 2020-06-30 | 0.00 | -0.01 | — | — |
| 2020-03-31 | 0.00 | -0.01 | — | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.